Core Insights - DarioHealth Corp. has published a study demonstrating significant blood glucose improvements among over 22,000 users of its platform, emphasizing the role of engagement in clinical outcomes [1][2] - The study utilized machine learning to analyze real-world data from 22,414 adults with type 2 diabetes, revealing distinct glycemic trajectories influenced by demographic, clinical, and engagement factors [1] - Higher digital engagement, particularly frequent blood glucose monitoring, was linked to more substantial and sustained glycemic improvements, with a threshold of 12 measurements per month identified as critical for positive outcomes [1] Company Overview - DarioHealth is a leading digital health company focused on transforming chronic condition management through a user-centric digital therapeutics platform [1] - The platform offers personalized interventions driven by data analytics and coaching for various health issues, including diabetes, hypertension, and weight management [1] - DarioHealth aims to provide continuous and customized care, moving away from traditional episodic healthcare approaches, thereby enhancing user satisfaction and retention [1] Research Findings - The study's findings indicate that engagement metrics serve as clinical signals that can impact return on investment (ROI) for employers and health plans [1] - Machine learning applications in the study allowed for the identification of user-specific responses and optimal intervention timing, enhancing personalized support for blood glucose management [1] - The research underscores Dario's capability to translate real-world data into measurable clinical impacts, making it a valuable partner for health plans and risk-bearing provider organizations [1]